Woodmont Investment Counsel’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRI
PIP
BFA
VNIM
OWP
ACM
RA
RHJA
EWM
Woodmont Investment Counsel's AMRI Position: Q4 2016 in Review
Woodmont Investment Counsel sold out of Albany Molecular Research Inc (AMRI) in Q4 2016, closing a stake of 4,773 shares — an estimated $79K sold.
Woodmont Investment Counsel first reported a position in AMRI in Q2 2013 and held it in 13 quarters. The position peaked at $1.69M in Q2 2013. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.
- Woodmont Investment Counsel reported no remaining Albany Molecular Research Inc position as of Q4 2016 after selling out during the quarter.
- Woodmont Investment Counsel sold 4,773 Albany Molecular Research Inc shares in Q4 2016, an estimated $79K.
- Woodmont Investment Counsel first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 13 quarters.
- Woodmont Investment Counsel's Albany Molecular Research Inc position peaked at $1.69M in Q2 2013.
- 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.
Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.